Woodcasting Versus Thermoplast Splint in CMC Arthroplasty
Launched by FOUNDATION FOR ORTHOPAEDIC RESEARCH AND EDUCATION · Mar 10, 2025
Trial Information
Current as of April 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different types of splints—woodcasting and thermoplast splints—used after surgery for carpometacarpal (CMC) joint arthritis. The goal is to see which splint patients prefer after undergoing a specific surgery called CMC arthroplasty, which helps relieve pain and improve function in the thumb joint.
To participate in this trial, you need to be over 18 years old and able to make your own medical decisions. You should also be eligible for the surgery and willing to follow the treatment plan for six weeks. However, pregnant women and those deemed unsuitable by the study leader cannot participate. If you join the trial, you'll help researchers understand which type of splint works best for patients like you, and your feedback will play an important role in improving care for others with CMC arthritis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients over the age of 18 years old.
- • Intact Medical Decision Making
- • Eligible for Surgical Intervention
- • Willing to comply with all aspects of the treatment and evaluation schedule over 6 weeks
- Exclusion Criteria:
- • Pregnant Women
- • Deemed Unsuitable by Principal Investigator
About Foundation For Orthopaedic Research And Education
The Foundation for Orthopaedic Research and Education (FORE) is a dedicated nonprofit organization committed to advancing the field of orthopaedics through innovative research and education. By fostering collaboration among healthcare professionals, researchers, and industry partners, FORE aims to enhance patient care and improve clinical outcomes. The foundation supports a wide range of clinical trials and educational initiatives, focusing on cutting-edge treatments and technologies that address musculoskeletal disorders. Through its commitment to scientific excellence and community outreach, FORE strives to elevate the standards of orthopaedic practice and contribute to the overall advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tampa, Florida, United States
Patients applied
Trial Officials
Michael Doarn, MD
Principal Investigator
Florida Orthopaedic Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported